Loading...

CORZ: Power Portfolio And AI Demand Will Unlock Substantial Upside

Published
23 Apr 25
Updated
03 Apr 26
Views
714
03 Apr
US$23.18
AnalystConsensusTarget's Fair Value
US$26.40
12.2% undervalued intrinsic discount
Loading
1Y
115.0%
7D
-3.4%

Author's Valuation

US$26.412.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 03 Apr 26

CORZ: AI Hosting Contracts And Power Expansion Will Drive Future Upside

Analysts have raised their blended price target on Core Scientific by a few dollars, placing it in the low to mid $20s. They cite progress on AI hosting contracts, expanded power capacity, and an ongoing shift in the power portfolio from Bitcoin mining toward high performance compute.

Analyst Commentary

Recent Street research sketches a mixed, but generally constructive, view on Core Scientific, with analysts adjusting price targets into a tight band around the low to mid $20s and focusing heavily on execution around AI hosting, power capacity and contract signings.

Bullish Takeaways

  • Bullish analysts highlight progress on organic growth, including a new Texas site and added power capacity at existing facilities, as supportive of the current valuation range in the low to mid $20s.
  • The planned shift of the full power portfolio from Bitcoin mining to AI and high performance compute is seen as a key execution pillar for long term growth, especially as Core Scientific builds out hosting commitments.
  • Several research notes point to the AI infrastructure ramp for CoreWeave and the 500MW under short exclusivity with an investment grade counterparty as important proof points for future capacity monetization.
  • Some bullish analysts view the recent upgrade and higher targets as reflecting confidence that additional AI or HPC colocation contracts can fill the expanding power pipeline over time.

Bearish Takeaways

  • More cautious analysts flag that some price targets have been trimmed, suggesting concerns about execution risk even as ratings remain positive overall.
  • The absence of a new lease announcement at the latest earnings update is framed as a timing issue, but it still underscores that the investment case relies heavily on converting current discussions into signed contracts.
  • Refinements to earnings models for 2026 and 2027 around the HPC segment highlight uncertainty on how quickly new capacity and contracts translate into financial results.
  • Core Scientific has been described as one of the weaker share price performers among peers with power infrastructure transitioning toward high performance compute, which may signal that the market wants clearer evidence of execution before rewarding the stock with higher valuation multiples.

What's in the News

  • U.S. crypto legislation talks reach an impasse as major banks decline to support a White House backed compromise on stablecoin rewards, with Core Scientific mentioned among publicly traded crypto related companies in focus (Reuters).
  • U.S. regulators signal readiness to outline crypto rules, keeping regulatory attention on listed crypto exposed names such as Core Scientific (WSJ).
  • The White House plans a meeting with banks and crypto firms, with Core Scientific referenced alongside other public crypto companies, highlighting ongoing policy engagement with the sector (Reuters).
  • European banks form Qivalis to work on a euro stablecoin, adding to global digital asset developments that frame the broader context for crypto infrastructure companies including Core Scientific (CoinDesk).
  • Core Scientific enters a multi year global partnership with the Cadillac Formula 1 Team as Official Data Center Partner, advising on high density data center design for the team’s new U.S. headquarters and race operations infrastructure.

Valuation Changes

  • Fair Value: Model fair value remains unchanged at $26.40, indicating no revision to the central valuation estimate in this update.
  • Discount Rate: The discount rate has risen slightly from 9.11% to 9.13%, a small move that modestly increases the hurdle applied to future cash flows.
  • Revenue Growth: Assumed long term revenue growth has been trimmed from 66.38% to 62.37%, signaling slightly more conservative expectations for top line expansion.
  • Net Profit Margin: The net profit margin assumption has risen from 29.94% to 32.21%, reflecting a higher modeled level of profitability on future revenue.
  • Future P/E: The future P/E multiple is effectively unchanged, moving only marginally from 29.15x to 29.16x in the updated framework.
27 viewsusers have viewed this narrative update

Key Takeaways

  • Reallocating resources from Bitcoin mining to HPC infrastructure could drive future growth amid rising data center demands and diversified clientele.
  • Debt restructuring and 0% interest funding improve growth potential and operational efficiencies through strategic hires, enhancing financial stability and earnings.
  • Dependency on CoreWeave, shift in strategy, restructuring uncertainties, and execution delays pose risks to growth and profitability.

Catalysts

About Core Scientific
    Provides digital asset mining services in the United States.
What are the underlying business or industry changes driving this perspective?
  • Core Scientific secured a major HPC contract with CoreWeave, with a total revenue potential of $8.7 billion over a 12-year term, significantly boosting future revenue compared to their current levels.
  • The company is expanding HPC infrastructure capacity by reallocating resources from Bitcoin mining, adding new sites, and extending existing ones, expecting to drive future revenue growth as data center needs rise.
  • Core Scientific’s ability to diversify its customer base and reduce reliance on CoreWeave as a primary client could improve margins and provide more stable revenue streams in the long term.
  • The improved balance sheet following significant debt restructuring and raising $625 million through a convertible note offering at 0% interest rates positions the company to effectively fund future growth initiatives with lower interest costs, improving net margins.
  • Strategic hires of data center professionals enhance execution capabilities, likely leading to increased operational efficiencies, positively impacting earnings as the company grows its data center business.
Core Scientific Earnings and Revenue Growth

Core Scientific Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Core Scientific's revenue will grow by 62.4% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -88.0% today to 32.2% in 3 years time.
  • Analysts expect earnings to reach $439.9 million (and earnings per share of $0.84) by about April 2029, up from -$280.7 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $935.3 million in earnings, and the most bearish expecting $98.7 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 29.2x on those 2029 earnings, up from -18.2x today. This future PE is lower than the current PE for the US Software industry at 30.0x.
  • Analysts expect the number of shares outstanding to grow by 5.88% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 9.13%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The shift from Bitcoin mining to HPC hosting and the resulting decline in digital asset hosted mining revenue, which was down significantly from $30 million to $6.5 million, could adversely impact overall revenue if the new strategy doesn't ramp up as expected.
  • The company faced a net loss of $265 million in the fourth quarter of 2024, an increase from the previous year's loss, raising concerns about its ability to reach profitability and improve net margins in the near term.
  • The dependency on a singular client, CoreWeave, for a significant portion of projected revenue introduces concentration risk. If CoreWeave's demand or business model shifts unfavorably, it could dramatically decrease Core Scientific's forecasted earnings.
  • With the recent Chapter 11 debt restructuring, there remains uncertainty about the company’s long-term financial health and its reliance on future capital expenditures, which could put strain on cash flow and negate earnings improvements.
  • The delayed rollout of planned HPC capacity expansions due to permitting and equipment issues could slow revenue growth and heighten execution risk, potentially impacting future earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $26.4 for Core Scientific based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $40.0, and the most bearish reporting a price target of just $20.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.4 billion, earnings will come to $439.9 million, and it would be trading on a PE ratio of 29.2x, assuming you use a discount rate of 9.1%.
  • Given the current share price of $16.23, the analyst price target of $26.4 is 38.5% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Core Scientific?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives